GeneDx Holdings (WGSWW) Other Non-Current Liabilities (2020 - 2025)
GeneDx Holdings has reported Other Non-Current Liabilities over the past 6 years, most recently at $1.6 million for Q4 2025.
- Quarterly results put Other Non-Current Liabilities at $1.6 million for Q4 2025, down 70.27% from a year ago — trailing twelve months through Dec 2025 was $1.6 million (down 70.27% YoY), and the annual figure for FY2025 was $1.6 million, down 70.27%.
- Other Non-Current Liabilities for Q4 2025 was $1.6 million at GeneDx Holdings, down from $4.3 million in the prior quarter.
- Over the last five years, Other Non-Current Liabilities for WGSWW hit a ceiling of $46.6 million in Q3 2021 and a floor of $1.6 million in Q4 2025.
- Median Other Non-Current Liabilities over the past 5 years was $10.2 million (2021), compared with a mean of $13.2 million.
- Biggest five-year swings in Other Non-Current Liabilities: crashed 90.35% in 2022 and later skyrocketed 403.56% in 2023.
- GeneDx Holdings' Other Non-Current Liabilities stood at $10.2 million in 2021, then surged by 134.46% to $24.0 million in 2022, then plummeted by 38.65% to $14.7 million in 2023, then crashed by 62.54% to $5.5 million in 2024, then tumbled by 70.27% to $1.6 million in 2025.
- The last three reported values for Other Non-Current Liabilities were $1.6 million (Q4 2025), $4.3 million (Q3 2025), and $3.3 million (Q2 2025) per Business Quant data.